Company Name, Ticker, Competitors, else..

Best Performing Stocks In Healthcare Sector During The Previous 90 Days

1 Day

Week

Current Month of April

30 Days

Current Quarter Q2 of 2025

90 Days

Ytd

12 Months

Shares are down by -12.37% on average, in Healthcare Sector during the previous 90 days.

Here are the best performing stocks in Healthcare Sector.

VAXX

$0.01

$0.0096

2,400.00%
Last 90 Days

VAXX

$0.01

$0.0096

2,400.00%

Vaxxinity Inc

Vaxxinity Inc shares went up 2,400.00% during the previous 90 days.

Vaxxinity Inc is a company that operates on a business model that focuses on the development and distribution of vaccines.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 1.265 mill.	$ - mill.	$ -56.934 mill.	127 mill.	-	Y/Y - %

Market Cap.	Revenues TTM	Net Income TTM
$ 1.265 mill.	$ - mill.	$ -56.934 mill.
Employees	Shares Outstanding	P/E
54	127 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y - %	MRQ Y/Y - %

NBIO

$0.0025

$0.0023

1,150.00%
Last 90 Days

NBIO

$0.0025

$0.0023

1,150.00%

Nascent Biotech Inc

Nascent Biotech Inc stock went up 1,150.00% during the previous 90 days.

Nascent Biotech Inc*s business model is focused on the development and commercialization of innovative therapies in the field of biotechnology. They aim to leverage their expertise and research to bring new drugs to market that can address critical unmet medical needs.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 0.427 mill.	$ - mill.	$ -1.925 mill.	171 mill.	-	Y/Y - %

Market Cap.	Revenues TTM	Net Income TTM
$ 0.427 mill.	$ - mill.	$ -1.925 mill.
Employees	Shares Outstanding	P/E
8	171 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y - %	MRQ Y/Y - %

UEEC

$0.2547

$0.1987

354.82%
Last 90 Days

UEEC

$0.2547

$0.1987

354.82%

United Health Products Inc

United Health Products Inc stock improved 354.82% during the previous 90 days.

United Health Products Inc. operates using a direct-to-consumer business model, providing innovative wound care products directly to customers. The company focuses on manufacturing and distributing wound dressings for different applications, offering a comprehensive range of solutions for both medical professionals and individuals seeking reliable wound management products. Overall, United Health Products Inc. aims to deliver effective, convenient, and high-quality wound care solutions directly to their target market.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 50.984 mill.	$ - mill.	$ -2.002 mill.	200 mill.	-	Y/Y - %

Market Cap.	Revenues TTM	Net Income TTM
$ 50.984 mill.	$ - mill.	$ -2.002 mill.
Employees	Shares Outstanding	P/E
-	200 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y - %	MRQ Y/Y - %

EGRX

$1.8

$1.1500

176.92%
Last 90 Days

EGRX

$1.8

$1.1500

176.92%

Eagle Pharmaceuticals inc

Eagle Pharmaceuticals Inc stock improved 176.92% during the previous 90 days.

Eagle Pharmaceuticals is a specialty pharmaceutical company that focuses on developing and commercializing injectable products. Their business model revolves around identifying existing drugs and developing innovative formulations or delivery systems that offer distinct advantages. They primarily target niche markets, partnering with contract manufacturers to efficiently produce and distribute their products to healthcare providers and patients.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 23.678 mill.	$ 257.551 mill.	$ 11.948 mill.	13 mill.	2.01	Y/Y -12.80 %

Market Cap.	Revenues TTM	Net Income TTM
$ 23.678 mill.	$ 257.551 mill.	$ 11.948 mill.
Employees	Shares Outstanding	P/E
117	13 mill.	2.01
Revenue Growth	Income Growth
MRQ Y/Y -12.80 %	MRQ Y/Y - %

GCAN

$0.0015

$0.0009

150.00%
Last 90 Days

GCAN

$0.0015

$0.0009

150.00%

The Greater Cannabis Company Inc

The Greater Cannabis Company Inc stock increased 150.00% during the previous 90 days.

The Greater Cannabis Company Inc*s business model involves the cultivation, processing, and distribution of cannabis products. They aim to offer a wide range of cannabis-related goods to cater to the demands of both medical and recreational users.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 1.423 mill.	$ - mill.	$ -0.179 mill.	949 mill.	-	Y/Y - %

Market Cap.	Revenues TTM	Net Income TTM
$ 1.423 mill.	$ - mill.	$ -0.179 mill.
Employees	Shares Outstanding	P/E
-	949 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y - %	MRQ Y/Y - %

DRNK

$0.0005

$0.0003

150.00%
Last 90 Days

DRNK

$0.0005

$0.0003

150.00%

Noho, Inc.

Noho, Inc. stock increased 150.00% during the previous 90 days.

Noho, Inc. operates based on a business model that is not clearly known or defined, as information about their model is unavailable beyond their website.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 0.009 mill.	$ 1.177 mill.	$ -5.733 mill.	18 mill.	-	Y/Y 65.54 %

Market Cap.	Revenues TTM	Net Income TTM
$ 0.009 mill.	$ 1.177 mill.	$ -5.733 mill.
Employees	Shares Outstanding	P/E
-	18 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y 65.54 %	MRQ Y/Y - %

AXIM

$0.0041

$0.0024

141.18%
Last 90 Days

AXIM

$0.0041

$0.0024

141.18%

Axim Biotechnologies Inc

Axim Biotechnologies Inc shares improved 141.18% during the previous 90 days.

Axim Biotechnologies Inc*s business model revolves around developing and commercializing innovative pharmaceutical and nutraceutical products, primarily focusing on cannabinoid-based therapies.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 0.931 mill.	$ 0.093 mill.	$ -4.136 mill.	227 mill.	-	Y/Y 76.04 %

Market Cap.	Revenues TTM	Net Income TTM
$ 0.931 mill.	$ 0.093 mill.	$ -4.136 mill.
Employees	Shares Outstanding	P/E
45	227 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y 76.04 %	MRQ Y/Y - %

OPGN

$4.17

$2.4400

141.04%
Last 90 Days

OPGN

$4.17

$2.4400

141.04%

Opgen Inc

Opgen Inc shares went up 141.04% during the previous 90 days.

OpGen Inc*s business model revolves around providing molecular diagnostic solutions and informatics services to combat global healthcare challenges, particularly in the field of infectious diseases. They develop innovative technologies that assist healthcare professionals in identifying, treating, and preventing the spread of infectious pathogens.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 5.589 mill.	$ 1.965 mill.	$ -22.408 mill.	1 mill.	-	Y/Y -96.20 %

Market Cap.	Revenues TTM	Net Income TTM
$ 5.589 mill.	$ 1.965 mill.	$ -22.408 mill.
Employees	Shares Outstanding	P/E
22	1 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y -96.20 %	MRQ Y/Y - %

BIXT

$0.1794

$0.1000

125.94%
Last 90 Days

BIXT

$0.1794

$0.1000

125.94%

Bioxytran Inc

Bioxytran Inc shares went up 125.94% during the previous 90 days.

Bioxytran Inc*s business model revolves around developing and commercializing innovative therapeutic solutions, specifically focusing on oxygen therapeutics for various medical applications.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 21.229 mill.	$ - mill.	$ -2.380 mill.	118 mill.	-	Y/Y - %

Market Cap.	Revenues TTM	Net Income TTM
$ 21.229 mill.	$ - mill.	$ -2.380 mill.
Employees	Shares Outstanding	P/E
-	118 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y - %	MRQ Y/Y - %

TBIO

$0.9216

$0.5116

124.78%
Last 90 Days

TBIO

$0.9216

$0.5116

124.78%

Telesis Bio Inc

Telesis Bio Inc shares improved 124.78% during the previous 90 days.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 1.634 mill.	$ 13.962 mill.	$ -45.551 mill.	2 mill.	-	Y/Y -68.66 %

Market Cap.	Revenues TTM	Net Income TTM
$ 1.634 mill.	$ 13.962 mill.	$ -45.551 mill.
Employees	Shares Outstanding	P/E
11	2 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y -68.66 %	MRQ Y/Y - %

OTLC

$0.0584

$0.0309

112.36%
Last 90 Days

OTLC

$0.0584

$0.0309

112.36%

Oncotelic Therapeutics Inc

Oncotelic Therapeutics Inc stock improved 112.36% during the previous 90 days.

Oncotelic Therapeutics Inc is a biotechnology company that focuses on developing and commercializing novel therapeutics for the treatment of cancer. Their business model revolves around conducting research to develop innovative drugs and therapies, and subsequently bringing those products to market to generate revenue and improve patient outcomes in cancer treatment.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 23.786 mill.	$ - mill.	$ -4.916 mill.	407 mill.	-	Y/Y - %

Market Cap.	Revenues TTM	Net Income TTM
$ 23.786 mill.	$ - mill.	$ -4.916 mill.
Employees	Shares Outstanding	P/E
5	407 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y - %	MRQ Y/Y - %

PRTG

$8.39

$4.2900

104.63%
Last 90 Days

PRTG

$8.39

$4.2900

104.63%

Portage Biotech Inc

Portage Biotech Inc shares increased 104.63% during the previous 90 days.

Portage Biotech Inc.*s business model involves the identification and development of innovative therapeutics and healthcare solutions, leveraging a unique portfolio of biotechnology companies and their technologies.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 0.406 mill.	$ - mill.	$ -75.382 mill.	0 mill.	-	Y/Y - %

Market Cap.	Revenues TTM	Net Income TTM
$ 0.406 mill.	$ - mill.	$ -75.382 mill.
Employees	Shares Outstanding	P/E
11	0 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y - %	MRQ Y/Y - %

YHGJ

$1.0254

$0.4564

80.21%
Last 90 Days

YHGJ

$1.0254

$0.4564

80.21%

Yunhong Green Cti Ltd

Yunhong Green Cti Ltd shares went up 80.21% during the previous 90 days.

Yunhong Green Cti Ltd operates with a business model focused on providing sustainable and environmentally friendly solutions. Their approach involves developing and manufacturing eco-friendly and innovative products that aim to reduce carbon emissions and promote energy efficiency. By leveraging their expertise in green technology, the company strives to contribute to a greener future while meeting the needs of customers.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 26.505 mill.	$ 17.240 mill.	$ -1.796 mill.	26 mill.	-	Y/Y 94.12 %

Market Cap.	Revenues TTM	Net Income TTM
$ 26.505 mill.	$ 17.240 mill.	$ -1.796 mill.
Employees	Shares Outstanding	P/E
-	26 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y 94.12 %	MRQ Y/Y - %

ORGS

$2.19

$0.8000

57.55%
Last 90 Days

ORGS

$2.19

$0.8000

57.55%

Orgenesis Inc

Orgenesis Inc shares increased 57.55% during the previous 90 days.

Orgenesis Inc operates under a business model focused on the development and commercialization of technologies related to cell and gene therapies. They collaborate with academic institutions and hospitals to identify potential therapies, and then use their expertise in advanced manufacturing and cell therapy technologies to scale production and develop clinical protocols. Through partnerships and licensing agreements, Orgenesis aims to bring these innovative therapies to market and improve the lives of patients with chronic diseases.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 10.326 mill.	$ 0.989 mill.	$ 35.260 mill.	5 mill.	0.30	Y/Y 215.45 %

Market Cap.	Revenues TTM	Net Income TTM
$ 10.326 mill.	$ 0.989 mill.	$ 35.260 mill.
Employees	Shares Outstanding	P/E
146	5 mill.	0.30
Revenue Growth	Income Growth
MRQ Y/Y 215.45 %	MRQ Y/Y 148.75 %

ECGI

$0.0018

$0.0005

38.46%
Last 90 Days

ECGI

$0.0018

$0.0005

38.46%

Event Cardio Group Inc.

Event Cardio Group Inc. shares improved 38.46% during the previous 90 days.

Event Cardio Group Inc. operates on a revenue sharing model by providing mobile cardiac telemetry (MCT) monitoring services to healthcare providers. The company partners with cardiology practices, hospitals, and research institutions, offering their MCT devices for use in detecting arrhythmias and monitoring heart patients remotely. They generate income by charging a percentage of the reimbursement received by healthcare providers for the MCT services provided.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 0.242 mill.	$ - mill.	$ -1.900 mill.	134 mill.	-	Y/Y - %

Market Cap.	Revenues TTM	Net Income TTM
$ 0.242 mill.	$ - mill.	$ -1.900 mill.
Employees	Shares Outstanding	P/E
1	134 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y - %	MRQ Y/Y - %

WGS

$94.21

$24.7300

35.59%
Last 90 Days

WGS

$94.21

$24.7300

35.59%

Genedx Holdings Corp

Genedx Holdings Corp shares went up 35.59% during the previous 90 days.

Genedx Holdings Corp operates as a genetic testing company, offering molecular and biochemical testing services for various genetic disorders and diseases. The company generates revenue by providing testing services to medical professionals and institutions around the world, aiding in accurate diagnosis and treatment planning for patients.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 2,539.105 mill.	$ 305.397 mill.	$ -52.286 mill.	27 mill.	-	Y/Y 66.30 %

Market Cap.	Revenues TTM	Net Income TTM
$ 2,539.105 mill.	$ 305.397 mill.	$ -52.286 mill.
Employees	Shares Outstanding	P/E
202	27 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y 66.30 %	MRQ Y/Y - %

CYDY

$0.204

$0.0532

35.28%
Last 90 Days

CYDY

$0.204

$0.0532

35.28%

Cytodyn inc

Cytodyn Inc stock increased 35.28% during the previous 90 days.

Cytodyn Inc is a biotechnology company that focuses on the development and commercialization of innovative treatments for a range of diseases, including cancer and viral infections. The company primarily generates revenue through the licensing and sale of its therapeutics to medical institutions and pharmaceutical companies. Cytodyn*s business model revolves around the research and development of novel drugs, conducting clinical trials, and forming strategic partnerships to bring their innovative treatments to market.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 250.565 mill.	$ - mill.	$ -7.086 mill.	1,228 mill.	36.63	Y/Y - %

Market Cap.	Revenues TTM	Net Income TTM
$ 250.565 mill.	$ - mill.	$ -7.086 mill.
Employees	Shares Outstanding	P/E
23	1,228 mill.	36.63
Revenue Growth	Income Growth
MRQ Y/Y - %	MRQ Y/Y - %

XERS

$4.065

$0.8650

27.03%
Last 90 Days

XERS

$4.065

$0.8650

27.03%

Xeris Biopharma Holdings Inc

Xeris Biopharma Holdings Inc stock increased 27.03% during the previous 90 days.

Xeris Biopharma Holdings Inc*s business model focuses on developing and commercializing innovative therapeutics for various medical conditions.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 602.455 mill.	$ 203.070 mill.	$ 2.268 mill.	148 mill.	-	Y/Y 35.39 %

Market Cap.	Revenues TTM	Net Income TTM
$ 602.455 mill.	$ 203.070 mill.	$ 2.268 mill.
Employees	Shares Outstanding	P/E
65	148 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y 35.39 %	MRQ Y/Y - %

NWBO

$0.352

$0.0720

25.71%
Last 90 Days

NWBO

$0.352

$0.0720

25.71%

Northwest Biotherapeutics Inc

Northwest Biotherapeutics Inc shares improved 25.71% during the previous 90 days.

Northwest Biotherapeutics Inc*s business model focuses on the development and commercialization of personalized immunotherapy products for the treatment of cancer.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 428.394 mill.	$ 1.382 mill.	$ -85.192 mill.	1,217 mill.	-	Y/Y -43.10 %

Market Cap.	Revenues TTM	Net Income TTM
$ 428.394 mill.	$ 1.382 mill.	$ -85.192 mill.
Employees	Shares Outstanding	P/E
25	1,217 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y -43.10 %	MRQ Y/Y - %

PTGX

$46.08

$9.2600

25.15%
Last 90 Days

PTGX

$46.08

$9.2600

25.15%

Protagonist Therapeutics inc

Protagonist Therapeutics Inc shares improved 25.15% during the previous 90 days.

Protagonist Therapeutics Inc*s business model focuses on the development and commercialization of novel peptide-based therapeutics.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 2,997.793 mill.	$ 434.433 mill.	$ 275.188 mill.	65 mill.	11.67	Y/Y 184.40 %

Market Cap.	Revenues TTM	Net Income TTM
$ 2,997.793 mill.	$ 434.433 mill.	$ 275.188 mill.
Employees	Shares Outstanding	P/E
112	65 mill.	11.67
Revenue Growth	Income Growth
MRQ Y/Y 184.40 %	MRQ Y/Y 381.70 %

ATAO

$0.0425

$0.0079

22.83%
Last 90 Days

ATAO

$0.0425

$0.0079

22.83%

Altair International Corp

Altair International Corp stock improved 22.83% during the previous 90 days.

Altair International Corp is a diversified company with a business model focused on providing a range of products and services. Their offerings span various sectors, including technology, finance, health, and real estate. By leveraging their expertise and network, Altair International Corp aims to capitalize on opportunities and generate revenue through strategic investments, partnerships, and market expansion.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 1.394 mill.	$ - mill.	$ -0.258 mill.	33 mill.	-	Y/Y - %

Market Cap.	Revenues TTM	Net Income TTM
$ 1.394 mill.	$ - mill.	$ -0.258 mill.
Employees	Shares Outstanding	P/E
10	33 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y - %	MRQ Y/Y - %

GH

$44.97

$8.3100

22.67%
Last 90 Days

GH

$44.97

$8.3100

22.67%

Guardant Health Inc

Guardant Health Inc stock increased 22.67% during the previous 90 days.

Guardant Health Inc*s business model revolves around providing advanced genomic testing services for cancer patients. It specializes in developing liquid biopsy tests that analyze circulating tumor DNA (ctDNA) in the blood. These tests help in early cancer detection, treatment selection, and monitoring of cancer progression. Guardant Health Inc collaborates with healthcare providers, pharmaceutical companies, and researchers to provide these innovative tests and contribute to the advancement of precision medicine in oncology.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 5,512.274 mill.	$ 739.016 mill.	$ -436.373 mill.	123 mill.	-	Y/Y 30.16 %

Market Cap.	Revenues TTM	Net Income TTM
$ 5,512.274 mill.	$ 739.016 mill.	$ -436.373 mill.
Employees	Shares Outstanding	P/E
1,779	123 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y 30.16 %	MRQ Y/Y - %

BTCY

$0.42

$0.0700

20.00%
Last 90 Days

BTCY

$0.42

$0.0700

20.00%

Biotricity Inc

Biotricity Inc shares went up 20.00% during the previous 90 days.

The business model of Biotricity Inc focuses on providing medical technology solutions through the development and commercialization of innovative biomedical devices and services. The company leverages its expertise in remote patient monitoring, data analytics, and artificial intelligence to deliver personalized healthcare solutions to both patients and healthcare professionals. Biotricity Inc aims to improve patient outcomes, reduce healthcare costs, and enhance the overall efficiency of the healthcare system.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 10.178 mill.	$ 13.095 mill.	$ -12.896 mill.	24 mill.	-	Y/Y 21.73 %

Market Cap.	Revenues TTM	Net Income TTM
$ 10.178 mill.	$ 13.095 mill.	$ -12.896 mill.
Employees	Shares Outstanding	P/E
15	24 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y 21.73 %	MRQ Y/Y - %

FNCH

$13

$2.0550

18.78%
Last 90 Days

FNCH

$13

$2.0550

18.78%

Finch Therapeutics Group Inc

Finch Therapeutics Group Inc stock improved 18.78% during the previous 90 days.

Finch Therapeutics Group Inc*s business model revolves around developing microbiome-based therapies for various diseases and conditions.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 20.875 mill.	$ - mill.	$ -12.575 mill.	2 mill.	-	Y/Y - %

Market Cap.	Revenues TTM	Net Income TTM
$ 20.875 mill.	$ - mill.	$ -12.575 mill.
Employees	Shares Outstanding	P/E
63	2 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y - %	MRQ Y/Y - %

ACUT

$0.56

$0.0857

18.07%
Last 90 Days

ACUT

$0.56

$0.0857

18.07%

Accustem Sciences Inc

Accustem Sciences Inc shares went up 18.07% during the previous 90 days.

Accustem Sciences Inc is a company that operates on a subscription-based business model with a focus on providing personalized health solutions. They offer genetic testing services and use the results to create customized plans, including nutrition and exercise recommendations, to improve overall health and prevent diseases. The company aims to enhance the well-being of individuals by leveraging genetic insights and promoting proactive health management.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 6.484 mill.	$ - mill.	$ -1.505 mill.	12 mill.	-	Y/Y - %

Market Cap.	Revenues TTM	Net Income TTM
$ 6.484 mill.	$ - mill.	$ -1.505 mill.
Employees	Shares Outstanding	P/E
-	12 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y - %	MRQ Y/Y - %

HLYK

$0.0292

$0.0042

16.80%
Last 90 Days

HLYK

$0.0292

$0.0042

16.80%

Healthlynked Corp

Healthlynked Corp shares improved 16.80% during the previous 90 days.

Healthlynked Corp is a healthcare network company that connects patients with physicians and other providers through their mobile application, offering various features like online appointment booking, access to medical records, and health management tools. The company generates revenue through subscription fees paid by providers to be listed on their platform and through advertising and sponsorship agreements with healthcare-related companies.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 8.952 mill.	$ 3.008 mill.	$ -6.131 mill.	307 mill.	-	Y/Y -53.55 %

Market Cap.	Revenues TTM	Net Income TTM
$ 8.952 mill.	$ 3.008 mill.	$ -6.131 mill.
Employees	Shares Outstanding	P/E
-	307 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y -53.55 %	MRQ Y/Y - %

GPFT

$0.0007

$0.0001

16.67%
Last 90 Days

GPFT

$0.0007

$0.0001

16.67%

Grapefruit Usa Inc

Grapefruit Usa Inc stock improved 16.67% during the previous 90 days.

Grapefruit USA Inc operates as a fully licensed cannabis distribution and manufacturing company. They focus on producing premium, high-quality cannabis products and efficiently distributing them to licensed retailers in the United States.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 0.402 mill.	$ 0.035 mill.	$ -4.367 mill.	574 mill.	-	Y/Y -98.07 %

Market Cap.	Revenues TTM	Net Income TTM
$ 0.402 mill.	$ 0.035 mill.	$ -4.367 mill.
Employees	Shares Outstanding	P/E
-	574 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y -98.07 %	MRQ Y/Y - %

PLX

$2.59

$0.3700

16.67%
Last 90 Days

PLX

$2.59

$0.3700

16.67%

Protalix Biotherapeutics inc

Protalix Biotherapeutics Inc shares increased 16.67% during the previous 90 days.

Protalix Biotherapeutics Inc. operates under a business model focused on the development, production, and commercialization of recombinant therapeutic proteins using plant cell culture technology, aiming to address unmet medical needs and provide innovative treatment options to patients worldwide.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 189.847 mill.	$ 53.399 mill.	$ 2.932 mill.	73 mill.	287.43	Y/Y 73.74 %

Market Cap.	Revenues TTM	Net Income TTM
$ 189.847 mill.	$ 53.399 mill.	$ 2.932 mill.
Employees	Shares Outstanding	P/E
61	73 mill.	287.43
Revenue Growth	Income Growth
MRQ Y/Y 73.74 %	MRQ Y/Y - %

LLY

$839.96

$114.2400

15.74%
Last 90 Days

LLY

$839.96

$114.2400

15.74%

Eli Lilly And Company

Eli Lilly And Company shares went up 15.74% during the previous 90 days.

Eli Lilly and Company operates as a global pharmaceutical firm that focuses on developing innovative medicines in areas such as diabetes, oncology, and neurodegeneration. Their business model emphasizes research and development, strategic partnerships, and a strong commitment to improving patient outcomes through advanced therapeutics.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 759,622.237 mill.	$ 45,042.700 mill.	$ 10,590.000 mill.	904 mill.	71.89	Y/Y 44.68 %

Market Cap.	Revenues TTM	Net Income TTM
$ 759,622.237 mill.	$ 45,042.700 mill.	$ 10,590.000 mill.
Employees	Shares Outstanding	P/E
43,000	904 mill.	71.89
Revenue Growth	Income Growth
MRQ Y/Y 44.68 %	MRQ Y/Y 101.39 %

ABT

$130.98

$17.5000

15.42%
Last 90 Days

ABT

$130.98

$17.5000

15.42%

Abbott Laboratories

Abbott Laboratories stock increased 15.42% during the previous 90 days.

Abbott Laboratories operates as a diversified healthcare company with a focus on developing and manufacturing a wide range of health-related products, including pharmaceuticals, medical devices, nutritional products, and diagnostic technologies. Their business model emphasizes innovation and quality, aiming to address the diverse needs of patients and healthcare providers across various sectors globally. By leveraging their expertise and extensive portfolio, Abbott strives to enhance patient outcomes and improve the overall quality of life.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 229,763.607 mill.	$ 41,950.000 mill.	$ 13,402.000 mill.	1,754 mill.	17.07	Y/Y 7.16 %

Market Cap.	Revenues TTM	Net Income TTM
$ 229,763.607 mill.	$ 41,950.000 mill.	$ 13,402.000 mill.
Employees	Shares Outstanding	P/E
114,000	1,754 mill.	17.07
Revenue Growth	Income Growth
MRQ Y/Y 7.16 %	MRQ Y/Y 478.98 %

GILD

$104.54

$12.7000

13.83%
Last 90 Days

GILD

$104.54

$12.7000

13.83%

Gilead Sciences Inc

Gilead Sciences Inc shares went up 13.83% during the previous 90 days.

Gilead Sciences Incs business model centers on researching, developing, and marketing innovative medicines, primarily targeting antiviral therapies. They focus on addressing unmet medical needs to enhance patient health globally.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 132,050.526 mill.	$ 28,754.000 mill.	$ 480.000 mill.	1,263 mill.	290.80	Y/Y 6.40 %

Market Cap.	Revenues TTM	Net Income TTM
$ 132,050.526 mill.	$ 28,754.000 mill.	$ 480.000 mill.
Employees	Shares Outstanding	P/E
18,000	1,263 mill.	290.80
Revenue Growth	Income Growth
MRQ Y/Y 6.40 %	MRQ Y/Y 25.83 %

VYST

$0.1088

$0.0118

12.16%
Last 90 Days

VYST

$0.1088

$0.0118

12.16%

Vystar Corporation

Vystar Corporation shares improved 12.16% during the previous 90 days.

Vystar Corporation*s business model revolves around the development, manufacturing, and distribution of innovative eco-friendly products, primarily focused on the rubber industry.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 1.446 mill.	$ 0.148 mill.	$ -6.599 mill.	13 mill.	-	Y/Y -12.02 %

Market Cap.	Revenues TTM	Net Income TTM
$ 1.446 mill.	$ 0.148 mill.	$ -6.599 mill.
Employees	Shares Outstanding	P/E
151	13 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y -12.02 %	MRQ Y/Y - %

AONC

$6

$0.6100

11.32%
Last 90 Days

AONC

$6

$0.6100

11.32%

American Oncology Network Inc

American Oncology Network Inc shares improved 11.32% during the previous 90 days.

American Oncology Network Inc is a healthcare services company that operates as a physician-led organization, providing comprehensive, community-based oncology care across the United States. They partner with oncologists, hospitals, and practices to deliver high-quality, value-based cancer care while focusing on patient-centric solutions.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 26.784 mill.	$ 1,759.484 mill.	$ -26.958 mill.	4 mill.	-	Y/Y -47.94 %

Market Cap.	Revenues TTM	Net Income TTM
$ 26.784 mill.	$ 1,759.484 mill.	$ -26.958 mill.
Employees	Shares Outstanding	P/E
300	4 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y -47.94 %	MRQ Y/Y - %

XCUR

$11.18

$1.1100

11.02%
Last 90 Days

XCUR

$11.18

$1.1100

11.02%

Exicure Inc

Exicure Inc stock increased 11.02% during the previous 90 days.

Exicure Inc operates on a business model focused on developing and commercializing transformative gene therapy drugs utilizing its proprietary spherical nucleic acid (SNA) technology. The company aims to leverage its platform to create therapeutic solutions for various diseases by delivering genetic medicines directly to cells. By collaborating with partners or independently, Exicure Inc aims to advance its pipeline and ultimately bring innovative treatments to the market.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 22.833 mill.	$ - mill.	$ -9.701 mill.	2 mill.	-	Y/Y - %

Market Cap.	Revenues TTM	Net Income TTM
$ 22.833 mill.	$ - mill.	$ -9.701 mill.
Employees	Shares Outstanding	P/E
31	2 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y - %	MRQ Y/Y - %

LNTH

$101.32

$9.8500

10.77%
Last 90 Days

LNTH

$101.32

$9.8500

10.77%

Lantheus Holdings Inc

Lantheus Holdings Inc shares improved 10.77% during the previous 90 days.

Lantheus Holdings Inc operates as a medical imaging company that develops and commercializes diagnostic imaging agents. The company focuses on providing innovative imaging agents to enhance medical diagnostics processes and improve patient outcomes. Lantheus mainly generates revenue from the sales of its products and imaging agents to healthcare providers and institutions globally.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 7,260.693 mill.	$ 1,533.291 mill.	$ 312.442 mill.	72 mill.	23.11	Y/Y 10.57 %

Market Cap.	Revenues TTM	Net Income TTM
$ 7,260.693 mill.	$ 1,533.291 mill.	$ 312.442 mill.
Employees	Shares Outstanding	P/E
834	72 mill.	23.11
Revenue Growth	Income Growth
MRQ Y/Y 10.57 %	MRQ Y/Y - %

XGN

$4.385

$0.3950

9.90%
Last 90 Days

XGN

$4.385

$0.3950

9.90%

Exagen Inc

Exagen Inc stock went up 9.90% during the previous 90 days.

Exagen Inc*s business model revolves around providing diagnostic testing solutions in the field of autoimmune diseases.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 79.855 mill.	$ 55.112 mill.	$ -0.012 mill.	18 mill.	-	Y/Y -4.64 %

Market Cap.	Revenues TTM	Net Income TTM
$ 79.855 mill.	$ 55.112 mill.	$ -0.012 mill.
Employees	Shares Outstanding	P/E
209	18 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y -4.64 %	MRQ Y/Y -37.28 %

ZLAB

$28.39

$2.3400

8.98%
Last 90 Days

ZLAB

$28.39

$2.3400

8.98%

Zai Lab Limited

Zai Lab Limited stock increased 8.98% during the previous 90 days.

Zai Lab Limited operates as a biopharmaceutical company primarily in China. The company seeks to discover, develop, and commercialize innovative medicines to address unmet medical needs in the country. Zai Lab focuses on licensing and acquiring clinical stage or late-stage development drugs, and then progressing them through regulatory approval and commercial launch.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 28,073.670 mill.	$ 398.988 mill.	$ -257.103 mill.	989 mill.	-	Y/Y 65.68 %

Market Cap.	Revenues TTM	Net Income TTM
$ 28,073.670 mill.	$ 398.988 mill.	$ -257.103 mill.
Employees	Shares Outstanding	P/E
656	989 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y 65.68 %	MRQ Y/Y - %

DGX

$163.8

$12.6000

8.33%
Last 90 Days

DGX

$163.8

$12.6000

8.33%

Quest Diagnostics Inc

Quest Diagnostics Inc stock improved 8.33% during the previous 90 days.

Quest Diagnostics Inc operates as a leading provider of clinical laboratory and diagnostic information services, catering to patients, healthcare professionals, hospitals, and pharmaceutical companies. The company generates revenue through a comprehensive suite of diagnostic testing services, encompassing routine lab tests, advanced molecular diagnostics, and a variety of specialized tests tailored to support clinical decision-making and patient care.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 18,552.640 mill.	$ 9,872.000 mill.	$ 921.000 mill.	113 mill.	21.36	Y/Y 14.55 %

Market Cap.	Revenues TTM	Net Income TTM
$ 18,552.640 mill.	$ 9,872.000 mill.	$ 921.000 mill.
Employees	Shares Outstanding	P/E
48,000	113 mill.	21.36
Revenue Growth	Income Growth
MRQ Y/Y 14.55 %	MRQ Y/Y 15.12 %

PTCT

$47.14

$3.3000

7.53%
Last 90 Days

PTCT

$47.14

$3.3000

7.53%

Ptc Therapeutics inc

Ptc Therapeutics Inc shares increased 7.53% during the previous 90 days.

PTC Therapeutics Inc*s business model revolves around the research, development, and commercialization of innovative treatments for rare and genetic diseases.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 3,620.661 mill.	$ 900.028 mill.	$ -320.204 mill.	77 mill.	-	Y/Y -12.88 %

Market Cap.	Revenues TTM	Net Income TTM
$ 3,620.661 mill.	$ 900.028 mill.	$ -320.204 mill.
Employees	Shares Outstanding	P/E
995	77 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y -12.88 %	MRQ Y/Y - %

JNJ

$157.47

$10.4400

7.10%
Last 90 Days

JNJ

$157.47

$10.4400

7.10%

Johnson and Johnson

Johnson And Johnson shares improved 7.10% during the previous 90 days.

Johnson & Johnson operates as a multinational healthcare company with a diversified business model that spans pharmaceuticals, medical devices, and consumer health products. By focusing on innovation and strategic acquisitions, the company aims to improve global health and well-being.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 382,551.472 mill.	$ 88,821.000 mill.	$ 14,066.000 mill.	2,429 mill.	27.12	Y/Y 5.26 %

Market Cap.	Revenues TTM	Net Income TTM
$ 382,551.472 mill.	$ 88,821.000 mill.	$ 14,066.000 mill.
Employees	Shares Outstanding	P/E
134,400	2,429 mill.	27.12
Revenue Growth	Income Growth
MRQ Y/Y 5.26 %	MRQ Y/Y -15.26 %